Skip to content
Trial Eligibility
Menu

Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa

NCT07213973

This study is recruiting at 24 US sites in 17 states, according to its ClinicalTrials.gov record last updated .

Summary

The purpose of this study is to evaluate the pharmacokinetics, safety, and efficacy of povorcitinib in adolescent participants with moderate to severe hidradenitis suppurativa over a 54-week open-label treatment period.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Hidradenitis Suppurativa (HS)

Eligibility basics and study details

Study type
Interventional
Phase
Phase 2
Ages
12 to 17 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
Incyte Corporation
Last updated on ClinicalTrials.gov
October 9, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Alabama · 1

  • University of Alabama At Birmingham · Birmingham, AL

Arizona · 2

  • Medical Dermatology Specialists Phoenix · Phoenix, AZ
  • Saguaro Dermatology · Phoenix, AZ

Connecticut · 1

  • Uconn Health · Farmington, CT

Florida · 3

  • Skin Research of South Florida, Llc · Miami, FL
  • University of Miami Miller School of Medicine · Miami, FL
  • Trueblue Clinical Research · Tampa, FL

Georgia · 1

  • Advanced Medical Research Pc · Sandy Springs, GA

Illinois · 1

  • Endeavor Health Medical Group · Skokie, IL

Kansas · 1

  • Dermatology Skin Cancer Center Leawood · Leawood, KS

Kentucky · 1

  • Equity Medical · Bowling Green, KY

Maryland · 1

  • Johns Hopkins Univ Schl of Medicine · Baltimore, MD

Massachusetts · 1

  • Boston Childrens Hospital · Boston, MA

Michigan · 3

  • Oakland Hills Dermatology Pc · Auburn Hills, MI
  • Wayne State University Physician Group Dermatology · Detroit, MI
  • Revival Research Institute, Llc Troy · Troy, MI

Missouri · 1

  • Washington University · St Louis, MO

Montana · 1

  • Boeson Research Missoula 2825 Fort Missoula Rd · Missoula, MT

New Mexico · 1

  • University of New Mexico Hospital · Albuquerque, NM

Pennsylvania · 1

  • Geisinger Medical Center · Danville, PA

Texas · 3

  • Bellaire Dermatology Associates Bda · Bellaire, TX
  • Texas Dermatology Research Center · Dallas, TX
  • 3A Research Llc West Location · El Paso, TX

Utah · 1

  • Jordan Valley Dermatology Center · South Jordan, UT

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.